Skip to main content

Hyperpolarized ultra-low field (ULF) magnetic resonance to design next generation functional contrast agents

Project description

Novel contrast agents that stay visible longer enhance medical imaging

The ability to non-invasively visualise the human body has played a critical role in enhancing the diagnosis, treatment and outcomes of numerous diseases. Nuclear magnetic resonance (NMR) imaging is one of those powerful imaging techniques that helps clinicians see cells and tissues and observe physiological processes. Signal enhancement methods have been developed to overcome sensitivity challenges of NMR and molecules with highly enhanced signals have in recent years been introduced as contrast agents for biomedical imaging. However, these agents are only active for a couple of minutes. The EU-funded HyperULFNMR project is designing functional contrast molecules for a class of NMR devices that will have significantly longer lifetimes and simultaneously reveal molecular coupling patterns, spurring advances in both research and diagnostics.

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 1 500 000,00
Address
Hofgartenstrasse 8
80539 Munchen
Germany
Activity type
Research Organisations
Non-EU contribution
€ 0,00

Beneficiaries (1)

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Germany
Net EU contribution
€ 1 500 000,00
Address
Hofgartenstrasse 8
80539 Munchen
Activity type
Research Organisations
Non-EU contribution
€ 0,00